Back to Search Start Over

Gallium-containing mesoporous nanoparticles influence in-vitro osteogenic and osteoclastic activity.

Authors :
Kurtuldu F
Mutlu N
Friedrich RP
Beltrán AM
Liverani L
Detsch R
Alexiou C
Galusek D
Boccaccini AR
Source :
Biomaterials advances [Biomater Adv] 2024 Sep; Vol. 162, pp. 213922. Date of Electronic Publication: 2024 Jun 05.
Publication Year :
2024

Abstract

Mesoporous silica nanoparticles were synthesized using a microemulsion-assisted sol-gel method, and calcium, gallium or a combination of both, were used as dopants. The influence of these metallic ions on the physicochemical properties of the nanoparticles was investigated by scanning and transmission electron microscopy, as well as N <subscript>2</subscript> adsorption-desorption methods. The presence of calcium had a significant impact on the morphology and textural features of the nanoparticles. The addition of calcium increased the average diameter of the nanoparticles from 80 nm to 150 nm, while decreasing their specific surface area from 972 m <superscript>2</superscript> /g to 344 m <superscript>2</superscript> /g. The nanoparticles of all compositions were spheroidal, with a disordered mesoporous structure. An ion release study in cell culture medium demonstrated that gallium was released from the nanoparticles in a sustained manner. In direct contact with concentrations of up to 100 μg/mL of the nanoparticles, gallium-containing nanoparticles did not exhibit cytotoxicity towards pre-osteoblast MC3T3-E1 cells. Moreover, in vitro cell culture tests revealed that the addition of gallium to the nanoparticles enhanced osteogenic activity. Simultaneously, the nanoparticles disrupted the osteoclast differentiation of RAW 264.7 macrophage cells. These findings suggest that gallium-containing nanoparticles possess favorable physicochemical properties and biological characteristics, making them promising candidates for applications in bone tissue regeneration, particularly for unphysiological or pathological conditions such as osteoporosis.<br />Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.<br /> (Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved.)

Details

Language :
English
ISSN :
2772-9508
Volume :
162
Database :
MEDLINE
Journal :
Biomaterials advances
Publication Type :
Academic Journal
Accession number :
38878645
Full Text :
https://doi.org/10.1016/j.bioadv.2024.213922